Interleukin-17-producing t-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation

Transplantation

Volumn 88, Issue 11, 2009, Pages 1261-1272

  Dander, Erica ^a   Balduzzi, Adriana ^b   Zappa, Greta ^a   Lucchini, Giovanna ^b   Perseghin, Paolo ^b   André, Valentina ^a   Todisco, Elisabetta ^c   Rahal, Daoud ^c   Migliavacca, Maddalena ^b   Longoni, Daniela ^b   Solinas, Graziella ^c   Villa, Antonello ^a   Berti, Emilio ^a   Mina, Pamela Della ^a,d   Parma, Matteo ^b   Allavena, Paola ^c   Biagi, Ettore ^a,b   Rovelli, Attilio ^b   Biondi, Andrea ^a,b   Dĝamico, Giovanna ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

GVHD; TH 17 cells; Transplantation

Indexed keywords

BUSULFAN; CD4 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOKINE; ETOPOSIDE; FLUDARABINE; INTERFERON; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR; MELPHALAN; METHOTREXATE; PREDNISONE; THIOTEPA; THYMOCYTE ANTIBODY; TREOSULFAN; AUTACOID; BIOLOGICAL MARKER; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; GAMMA INTERFERON; IL23R PROTEIN, HUMAN; INTERLEUKIN RECEPTOR;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT DYSFUNCTION; GRAFT VERSUS HOST REACTION; HELPER CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; REGULATORY T LYMPHOCYTE; ADOLESCENT; AGED; ALLOTRANSPLANTATION; BLOOD; CASE CONTROL STUDY; CHILD; CONFOCAL MICROSCOPY; FLOW CYTOMETRY; IMMUNOLOGY; INFANT; LIVER; LYMPHOCYTE COUNT; MIDDLE AGED; PRESCHOOL CHILD; SKIN; TIME;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; INTERLEUKIN-17; LIVER; LYMPHOCYTE COUNT; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; RECEPTORS, INTERLEUKIN; SKIN; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 73349105621     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181bc267e     Document Type: Article

References (49)

1. Goker H, Haznedaroglu IC, Chao NJ. Acute graft-vs-host disease: Pathobiology and management. Exp Hematol 2001; 29: 259.
2. Shlomchik WD. Graft-versus-host disease. Nat Rev Immunol 2007; 7: 340.
3. Ferrara JL, Cooke KR, Teshima T. Pathophysiology of graft-vs.-host disease. Semin Hematol 2006; 43: 3.
4. Welniak LA, Blazar BR, Murphy WJ. Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol 2007; 25: 139.
5. Blazar BR, Korngold R, Vallera DA. Recent advances in graft-versus-host disease (GVHD) prevention. Immunol Rev 1997; 157: 79.
6. Fowler DH, Kurasawa K, Smith R, et al. Donor CD4-enriched cells of Th2 cytokine phenotype regulate graft-versus-host disease without impairing allogeneic engraftment in sublethally irradiated mice. Blood 1994; 84: 3540.
7. Nikolic B, Lee S, Bronson RT, et al. Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets. J Clin Invest 2000; 105: 1289.
8. + effector T cells develop via lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6: 1123.
9. Rohn TA, Jennings GT, Hernandez M, et al. Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis. Eur J Immunol 2006; 36: 2857.
10. + Th cells that cause autoimmune arthritis. J Exp Med 2007; 204: 41.
11. Lowes MA, Kikuchi T, Fuentes-Duculan J, et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 2008; 128: 1207.
12. Annunziato F, Cosmi L, Santarlasci V, et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007; 204: 1849.
13. Iwakura Y, Ishigame H. The IL-23/IL-17 axis in inflammation. J Clin Invest 2006; 116: 1218.
14. Fossiez F, Banchereau J, Murray R, et al. Interleukin-17. Int Rev Immunol 1998; 16: 541.
15. Yi T, Zhao D, Lin CL, et al. Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft versus host disease. Blood2008; 112:2101.
16. Chen X, Vodanovic-Jankovic S, Johnson B, et al. Absence of regulatory Tcell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease. Blood 2007; 110: 3804.
17. Carlson MJ, West ML, Coghill JM. In vitro differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathology. Blood 2009; 113: 1365.
18. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945.
19. Pavletic SZ, Martin P, Lee SJ, et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease. IV. Response Criteria Working Group report. Biol Blood Marrow Transplant 2006; 12: 252.
20. Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235.
21. O'Garra A, Stockinger B, Veldhoen M. Differentiation of human Th-17 cells does require TGF-/3. Nat Immunol 2008; 9: 588.
22. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, et al. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007; 8: 942.
23. Paczesny S, Krijanovski OI, Braun TM, et al. A biomarker panel for acute graft-versus-host disease. Blood 2009; 113: 273.
24. Visentainer JE, Lieber SR, Persoli LB, et al. Serum cytokine levels and acute graft-versus-host disease after HLA-identical hematopoietic stem cell transplantation. Exp Hematol2003; 31: 1044.
25. + regulatory T cells in patients with chronic graft-versus-host disease. Blood 2005; 106: 2903.
26. Di Biasio, Di Maio L, Bugarin C, et al. Regulatory T cells and extracorporeal photochemotherapy: Correlation with clinical response and decreased frequency of proinflammatory T cells. Transplantation 2009; 87: 1422.
27. Bettelli E, Korn T, Oukka M, et al. Induction and effector functions of T(H)17 cells. Nature 2008; 453: 1051.
28. Veldhoen M, Hocking RJ, Atkins CJ, et al. TGF-beta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006; 24: 179.
29. Zhou L, Littman DR. Transcriptional regulatory networks in Th17 cell differentiation. Curr Opin Immunol 2009; 21: 1.
30. Dardalhon V, Korn T, Kuchroo VK, et al. Role of Th1 and Th17 cells in organ-specific autoimmunity. JAutoimmun 2008; 31: 252.
31. Veldhoen M, Hocking RJ, Flavell RA, et al. Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat Immunol 2006; 7: 1151.
32. Wong CK, Ho CY, Li EK, et al. Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 2000; 9: 589.
33. Kurasawa K, Hirose K, Sano H, et al. Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum 2000; 43:2455.
34. Nielsen OH, Kirman I, Rudiger N, et al. Upregulation of interleukin-12 and-17 in active inflammatory bowel disease. Scand J Gastroenterol 2003; 38: 180.
35. Fujino S, Andoh A, Bamba S, et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003; 52: 65.
36. Messi M, Giacchetto I, Nagata K, et al. Memory and flexibility of cytokine gene expression as separable properties of human TH1 and TH2 lymphocytes. Nat Immunol 2003; 4: 78.
37. Bettelli E, Korn T, Kuchroo VK. Th17: The third member of the effector T cell trilogy. Curr Opin Immunol 2007; 19: 652.
38. Harris TJ, Grosso JF, Yen HR, et al. An in vivo requirement for STAT3 signaling in Th17 development and Th17-dependent autoimmunity. JImmunol 2007; 179:4313.
39. Acosta-Rodriguez EV, Rivino L, Geginat J, et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 2007; 8: 639.
40. Nakamura H, Komatsu K, Ayaki M, et al. Serum levels of soluble IL-2 receptor, IL-12, IL-18, and IFN-gamma in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation. J Allergy Clin Immunol 2000; 106: S45.
41. Sakata N, Yasui M, OkamuraT, et al. Kinetics of plasma cytokines after hematopoietic stem cell transplantation from unrelated donors: The ratio of plasma IL-10/sTNFR level as a potential prognostic marker in severe acute graft-versus-host disease. Bone Marrow Transplant 2001; 27: 1153.
42. Fujii N, Hiraki A, Aoe K, et al. Serum cytokine concentrations and acute graft-versus-host disease after allogeneic peripheral blood stem cell transplantation: Concurrent measurement of ten cytokines and their respective ratios using cytometric bead array. Int J Mol Med 2006; 17: 881.
43. Mascarell L, Truffa-Bachi P. Cyclosporine A therapy differently affects immunological-relevant gene expression following immunization. Immunol Lett 2002; 84: 137.
44. Pène J, Chevalier S, Preisser L, et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol 2008; 180: 7423.
45. Ikeuchi H, KuroiwaT, HiramatsuN, et al. Expression ofinterleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheum 2005; 52: 1037.
46. Wolk K, Kunz S, Witte E, et al. IL-22 increases the innate immunity of tissues. Immunity 2004; 21: 241.
47. Tangsheng Y, Chen Y, Wang L, et al. Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft versus host disease. Blood (in press).
48. + T cell-mediated immunosuppression, suggesting dual roles in the disease process. J Immunol 2007; 178:6695.
49. Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6:1133.